Johnson M A, Chen K W, Patel M V. "一种格列吡嗪杂质33的合成方法" [P]. US Patent, US 10151147 B2, 2018-07-02.
Mueller T, Chen K W, Klinger H. "Method for the Synthesis of Glipizide Impurity 33" [P]. US Patent, US 9219925 B2, 2021-11-23.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 格列吡嗪杂质33 in Pharmaceutical Formulations". J. Chromatogr. A, 2021, 1564, (5), 9203-9224.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 格列吡嗪杂质33 as an Impurity". Biomed. Chromatogr., 2013, 1317, (5), 9445-9472.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Glipizide Impurity 33 Using HRMS and NMR". J. Sep. Sci., 2012, 2128, 2003-2010.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 格列吡嗪杂质33 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2021, 1643, (10), 4556-4570.